Organization · Venture Capital
BIF Partners
BIF Partners is a Hamburg-based private investment company specializing in venture capital investments from pre-seed to Series A stages, as well as club deals in more mature companies.
Overview
What BIF Partners does
What BIF Partners is
BIF Partners is a Hamburg-based private investment company specializing in venture capital investments from pre-seed to Series A stages, as well as club deals in more mature companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find BIF Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
BIF Partners as a funder
Investment thesis
BIF Partners backs experienced, highly driven teams with well-defined business ideas and clear value propositions that solve real customer problems. The firm focuses on digital technology, innovative and sustainable service concepts, and life science opportunities while remaining broadly industry and geography agnostic.
Focus narrative
BIF Partners invests across various sectors and is industry and geography agnostic. Their primary investment focus includes digital technology, innovative and sustainable service concepts, and life science opportunities. The firm emphasizes quick decision-making and strategic support for its portfolio companies.
Value beyond capital
BIF Partners provides capital, venture/private-equity experience, and network access to its portfolio companies. The firm emphasizes quick responses and avoids rigid investment processes, making it a flexible partner for startups.
Terms and economics
- Typical check
- $100,000–$1,500,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 14
Portfolio context
Notable portfolio companies include: Aptamer Group: Develops Optimer® binders for innovation in the life science industry. Atriva Therapeutics: A clinical-stage biopharmaceutical company targeting respiratory viral infections. Avatour: A remote collaboration platform for site meetings. Be Home: Aims to prolong the time individuals can live at home. Mahana Therapeutics: Develops digital treatments for chronic health conditions. Coldplasmatech: Produces medical devices that eliminate multiresistant bacteria in chronic wounds using cold plasma. Hemispherian: A biotechnology company focused on new treatments for aggressive cancer types. Io Tech: Develops digital multi-material solutions for electronics and additive mass manufacturing. Nelly: Simplifies patient onboarding and payments for medical practices. Plover Trip: Offers fully digitized business travel solutions. Tagworks Pharmaceuticals: Works on antibody-based imaging and therapy. ECO GROUP: Unites rising eco-brands. Joboo: A blue-collar employment platform in Germany. Nuuron: Developing a digital drug for Alzheimer’s Disease.
Common questions
What to know about BIF Partners
Upseed classifies BIF Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.